1. Home
  2. STRS vs NTHI Comparison

STRS vs NTHI Comparison

Compare STRS & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$26.79

Market Cap

168.1M

Sector

Real Estate

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$8.77

Market Cap

195.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
NTHI
Founded
1992
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.1M
195.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STRS
NTHI
Price
$26.79
$8.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.7K
65.5K
Earning Date
11-12-2025
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,912,000.00
$59,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.10
$3.20
52 Week High
$27.34
$25.00

Technical Indicators

Market Signals
Indicator
STRS
NTHI
Relative Strength Index (RSI) 65.48 50.62
Support Level $26.00 $8.11
Resistance Level $27.34 $10.19
Average True Range (ATR) 0.82 0.87
MACD 0.09 0.03
Stochastic Oscillator 86.45 35.89

Price Performance

Historical Comparison
STRS
NTHI

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: